Potential genetic therapies based on m6A methylation for skin regeneration: Wound healing and scars/keloids

Area of Science:

• Biochemistry
• Molecular Biology
• Dermatology

Background:

• Skin wound healing is a complex biological process prone to scar formation due to fibrotic tissue accumulation.
• Epigenetic modifications, including RNA methylation, are critical regulators of gene expression and cellular processes.
• N6-methyladenosine (m6A) is the most prevalent epitranscriptomic modification in eukaryotes, impacting mRNA and lncRNA function.

Purpose of the Study:

• To review the current understanding of RNA methylation's role in skin wound healing.
• To explore the specific mechanisms by which RNA methylation influences cell fate during healing.
• To discuss the therapeutic implications of targeting RNA methylation pathways for scar reduction and enhanced skin regeneration.

Main Methods:

• Literature review of studies on RNA methylation and skin wound healing.
• Analysis of regulatory pathways involving m6A modification in cellular processes.
• Examination of potential therapeutic targets within RNA methylation networks.

Main Results:

• RNA methylation, particularly m6A, significantly impacts gene expression dynamics during wound healing.
• Specific m6A regulators and readers are implicated in controlling fibroblast differentiation and extracellular matrix deposition.
• Dysregulation of m6A pathways can lead to aberrant fibrotic responses and scar formation.

Conclusions:

• RNA methylation is a key epigenetic mechanism governing skin wound healing outcomes.
• Targeting m6A pathways presents a promising therapeutic avenue for managing scar formation and promoting functional tissue repair.
• Further research into the precise molecular mechanisms is warranted to fully exploit the therapeutic potential of RNA methylation in dermatology.